IP Library Granted Patent US 10,492,924
Granted Patent B2
US 10,492,924 · App. 15/799,554 · Granted Dec 3, 2019

Lordotic expandable interbody implant

Inventors: Christopher Stein (Fallbrook, CA); Seth Gustine (Encinitas, CA)
Assignee: NuVasive, Inc.
A61F2/447A61F2002/30158A61F2002/30387A61F2002/30471A61F2002/30507A61F2002/30538A61F2002/30904
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,492,924
App. No.
15/799,554
Granted
Dec 3, 2019
Kind
B2
Abstract

An expandable spinal fusion implant including a housing, upper and lower endplates, a wedge positioned within the housing and between the upper and lower endplates and a drive mechanism to urge the wedge distally between the upper and lower endplates to increase the separation between the endplates and expand the overall height of the distal end of the implant.

Claims (24)

1. An expandable spinal fusion implant, comprising:

a housing having a first endwall, a second endwall, a first sidewall, and a second sidewall defining a hollow interior, wherein an overall length of the first sidewall is greater than an overall length of the first endwall;

an upper endplate and a lower endplate, the upper endplate having a first bone contacting surface and a first interior surface including a first ramp, the lower endplate having a second bone contacting surface and a second interior surface including a second ramp;

a wedge positioned within the hollow interior of the housing and between the first interior surface and second interior surface, the wedge including a first angled surface that engages the first ramp and a second angled surface that engages the second ramp; and

a drive mechanism in contact with the first endwall and the wedge, wherein the drive mechanism is configured to drive the wedge in a direction toward the first endwall such that the first angled surface of the wedge engages the first ramp and the second angled surface of the wedge engages the second ramp, moving the upper endplate and lower endplate from a collapsed configuration to an expanded configuration, wherein in the expanded configuration the implant has a maximum height adjacent the first endwall that is greater than a maximum height adjacent the second endwall, and wherein, in the expanded configuration, the implant has a maximum height adjacent the first sidewall that is greater than a maximum height adjacent the second sidewall and the maximum height adjacent the second endwall is a fixed non-adjustable height equal to a maximum height of the second endwall of the housing.

2. The implant of claim 1 , wherein a height of the housing is static.

3. The implant of claim 1 , wherein a height of the upper endplate increases in a first direction across the upper endplate towards the first endwall and parallel to the first sidewall, and also increases in a second direction across the upper endplate towards the first sidewall and parallel to the first endwall.

4. The implant of claim 3 , wherein a height of the lower endplate increases in the first direction across the lower endplate towards the first endwall and parallel to the first sidewall, and in the second direction across the lower endplate towards the first sidewall and parallel to the first endwall.

5. The implant of claim 1 , wherein the first sidewall has a length that is greater than a length of the second sidewall.

6. The implant of claim 1 , wherein the housing includes a static upper surface forming a third bone contacting surface which faces upward and extends from adjacent the second endwall to a position adjacent to the first bone contacting surface of the upper endplate, and the housing includes a static lower surface forming a fourth bone contacting surface which faces downward and extends from adjacent the second endwall to a position adjacent to the second bone contacting surface of the lower endplate, wherein in the expanded configuration the third bone contacting surface is co-planar with the first bone contacting surface of the upper endplate, and in the expanded configuration the fourth bone contacting surface is co-planar with the second bone contacting surface of the lower endplate.

7. The implant of claim 6 , wherein the drive mechanism engages with the first endwall and the second endwall is free of the drive mechanism.

8. The implant of claim 7 , wherein the upper endplate includes a first opening and the lower endplate includes a second opening such that a fusion aperture extends through the hollow housing between the upper and lower endplates.

9. The implant of claim 8 , wherein the fusion aperture is situated closer to the second endwall than the wedge.

10. The implant of claim 9 , wherein the wedge defines a wall of the fusion aperture such that the size of the fusion aperture increases as the implant is moved from the collapsed configuration to the expanded configuration.

11. The implant of claim 1 , wherein the first ramp has a radiused surface and the second ramp has a radiused surface.

12. The implant of claim 11 , wherein the first angled surface has a planar surface and the second angled surface has a planar surface.

13. The implant of claim 1 , wherein the drive mechanism includes a shaft with a first end rotatably coupled to the first endwall and a second end threadedly coupled to the wedge.

14. The implant of claim 13 , wherein the second end of the shaft of the drive mechanism is free of the second endwall.

15. The implant of claim 1 , wherein a distal end of the housing is tapered.

16. The implant of claim 1 , wherein the drive mechanism comprises a drive screw.

17. The implant of claim 1 , wherein the second endwall comprises a drive screw aperture.

18. The implant of claim 1 , wherein the second endwall comprises a graft delivery port.

19. The implant of claim 1 , wherein the second endwall comprises a channel configured to receive at least a portion of an insertion tool.

20. The implant of claim 1 , wherein the implant is configured for use in a transforaminal lumbar interbody fusion surgical procedure.

Assignments (2)
SECURITY INTEREST Recorded Feb 28, 2020
From: NUVASIVE, INC.; NUVASIVE CLINICAL SERVICES MONITORING, INC.; NUVASIVE CLINICAL SERVICES, INC.; NUVASIVE SPECIALIZED ORTHOPEDICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 052918/0595 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2017
From: STEIN, CHRISTOPHER; GUSTINE, SETH
To: NUVASIVE, INC.
Reel/Frame 043996/0551 →
Continuity (3)
Continuation 14456640 · Aug 11, 2014
Provisional Application 61864132 · Aug 9, 2013
Related Publication 20180064551A1 · Mar 8, 2018
Cited By (23)
US 12,186,202 US 12,208,020 US 12,213,893 US 12,239,544 US 12,268,614 US 12,295,865 US 12,318,308 US 12,364,529 US 12,376,969 US 12,390,343 US 12,414,863 US 12,427,031 US 12,427,036 US 12,433,757 US 12,440,349 US 12,447,026 US 12,458,509 US 12,485,019 US 12,521,252 US 12,533,241 US 12,558,232 US 12,616,582 US 12,635,998